|
Volumn 21, Issue 6, 2007, Pages 521-524
|
Selegiline transdermal system in major depressive disorder: profile report.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOAMINE OXIDASE INHIBITOR;
SELEGILINE;
AREA UNDER THE CURVE;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DIARRHEA;
DRUG ADMINISTRATION;
HALF LIFE TIME;
HEADACHE;
HUMAN;
INSOMNIA;
INTRADERMAL DRUG ADMINISTRATION;
MAJOR DEPRESSION;
TREATMENT OUTCOME;
XEROSTOMIA;
ADMINISTRATION, CUTANEOUS;
AREA UNDER CURVE;
DEPRESSIVE DISORDER, MAJOR;
DIARRHEA;
DRUG ADMINISTRATION SCHEDULE;
HALF-LIFE;
HEADACHE;
HUMANS;
MONOAMINE OXIDASE INHIBITORS;
SELEGILINE;
SLEEP INITIATION AND MAINTENANCE DISORDERS;
TREATMENT OUTCOME;
XEROSTOMIA;
|
EID: 34548181337
PISSN: 11727047
EISSN: None
Source Type: Journal
DOI: 10.2165/00023210-200721060-00007 Document Type: Article |
Times cited : (8)
|
References (0)
|